BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38158696)

  • 1. Transcriptional factor CCAAT enhancer binding protein beta inhibits epithelial-mesenchymal transition in cervical cancer via regulating attractin-like 1.
    Fang M; Zhou Y; Li Z; Li X
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(13):1-7. PubMed ID: 38158696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEF2C-AS1 regulates its nearby gene MEF2C to mediate cervical cancer cell malignant phenotypes in vitro.
    Guo Q; Zhang L; Zhao L; Pang X; Wang P; Sun H; Liu S
    Biochem Biophys Res Commun; 2022 Dec; 632():48-54. PubMed ID: 36198203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA LINC01305 silencing inhibits cell epithelial-mesenchymal transition in cervical cancer by inhibiting TNXB-mediated PI3K/Akt signalling pathway.
    Yan SP; Chu DX; Qiu HF; Xie Y; Wang CF; Zhang JY; Li WC; Guo RX
    J Cell Mol Med; 2019 Apr; 23(4):2656-2666. PubMed ID: 30697971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CEBPB regulates the migration, invasion and EMT of breast cancer cells by inhibiting THBS2 expression and O-fucosylation.
    Qi L; Sun B; Yang B; Lu S
    Hum Mol Genet; 2023 May; 32(11):1850-1863. PubMed ID: 36728807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATG9A modulated by miR-195-5p can boost the malignant progression of cervical cancer cells.
    Liu X; Liu Z; Liu Y; Wang N
    Epigenetics; 2023 Dec; 18(1):2257538. PubMed ID: 37782756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway.
    Li YM; Li XJ; Yang HL; Zhang YB; Li JC
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4688-4697. PubMed ID: 31210295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXP3‑induced LINC00885 promotes the proliferation and invasion of cervical cancer cells.
    Liu Y; Tu H; Zhang L; Xiong J; Li L
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA BBOX1-AS1 upregulates HOXC6 expression through miR-361-3p and HuR to drive cervical cancer progression.
    Xu J; Yang B; Wang L; Zhu Y; Zhu X; Xia Z; Zhao Z; Xu L
    Cell Prolif; 2020 Jul; 53(7):e12823. PubMed ID: 32515533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCAAT-enhancer-binding protein beta activation of MMP-1 gene expression in SW1353 cells: independent roles of extracellular signal-regulated and p90/ribosomal S6 kinases.
    Petrella BL; Armstrong DA; Vincenti MP
    J Cell Physiol; 2011 Dec; 226(12):3349-54. PubMed ID: 21344389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin inhibits human non-small cell lung cancer by regulating AMPK-CEBPB-PDL1 signaling pathway.
    Lu T; Li M; Zhao M; Huang Y; Bi G; Liang J; Chen Z; Zheng Y; Xi J; Lin Z; Zhan C; Jiang W; Wang Q; Tan L
    Cancer Immunol Immunother; 2022 Jul; 71(7):1733-1746. PubMed ID: 34837101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA
    Fan MJ; Zou YH; He PJ; Zhang S; Sun XM; Li CZ
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31092700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-361-Mediated Inhibition of HSP90 Expression and EMT in Cervical Cancer Is Counteracted by Oncogenic lncRNA NEAT1.
    Xu D; Dong P; Xiong Y; Yue J; Konno Y; Ihira K; Kobayashi N; Todo Y; Watari H
    Cells; 2020 Mar; 9(3):. PubMed ID: 32151082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. piRNA-14633 promotes cervical cancer cell malignancy in a METTL14-dependent m6A RNA methylation manner.
    Xie Q; Li Z; Luo X; Wang D; Zhou Y; Zhao J; Gao S; Yang Y; Fu W; Kong L; Sun T
    J Transl Med; 2022 Jan; 20(1):51. PubMed ID: 35093098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SNHG3/WISP2 Axis Promotes Hela Cell Migration and Invasion
    Xu D; Feng H; Ren Z; Li X; Jiang C; Chen Y; Liu L; Chen W; Cui Z; Cang S
    Cancer Genomics Proteomics; 2023 Dec; 20(6suppl):744-753. PubMed ID: 38035707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Golgi Phosphoprotein 3 Promotes Cervical Cancer Progression via Wnt/β-catenin Mediated Epithelial-Mesenchymal Transition.
    Yang H; Ma X; Song B; Wang D; Chai Z
    Ann Clin Lab Sci; 2023 Sep; 53(5):738-748. PubMed ID: 37945014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of RARα Suppresses Decidualization
    Huang C; Zhang Q; Ni T; Zhou T; Lv C; Li Y; Yan J; Chen ZJ
    Front Endocrinol (Lausanne); 2022; 13():753416. PubMed ID: 35663305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrantly enhanced melanoma-associated antigen (MAGE)-A3 expression facilitates cervical cancer cell proliferation and metastasis via actuating Wnt signaling pathway.
    Gao X; Chen G; Cai H; Wang X; Song K; Liu L; Qiu T; He Y
    Biomed Pharmacother; 2020 Feb; 122():109710. PubMed ID: 31918280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA GHET1 promotes cervical cancer progression through regulating AKT/mTOR and Wnt/β-catenin signaling pathways.
    Liu Z; Luo S; Wu M; Huang C; Shi H; Song X
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31682716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZNF471 modulates EMT and functions as methylation regulated tumor suppressor with diagnostic and prognostic significance in cervical cancer.
    Bhat S; Kabekkodu SP; Adiga D; Fernandes R; Shukla V; Bhandari P; Pandey D; Sharan K; Satyamoorthy K
    Cell Biol Toxicol; 2021 Oct; 37(5):731-749. PubMed ID: 33566221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.